FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2776033345> ?p ?o ?g. }

• W2776033345 abstract "Psoriasis vulgaris is a chronic, inflammatory skin disease characterized by a dysregulated immune response and it is associated with substantial systemic comorbidities. Biological drugs such as tumour necrosis factor (TNF)-α inhibitors can ameliorate the disease but are expensive. Biosimilar drugs have the same amino-acid sequence as the originator, but differences in manufacturing can affect biological activity, efficacy and tolerability.To explore potential differences in intracellular phosphorylation of signalling molecules in peripheral blood cells from patients with psoriasis treated with the TNF-α inhibitor infliximab compared with healthy controls, and to investigate if the phosphorylation pattern was influenced by switching from the originator infliximab to the biosimilar CT-P13.By flow cytometry, we measured phosphorylation of nuclear factor kappa B, extracellular signal-regulated kinase 1/2, p38 mitogen-activated protein kinase and signal transducer and activator of transcription 3, before and after TNF-α stimulation in monocytes and T, B, natural killer and CD3+ CD56+ cells from 25 patients with psoriasis treated with infliximab and 19 healthy controls.At inclusion, phosphorylation levels of peripheral blood mononuclear cells (PBMCs) were increased in patients with psoriasis compared with healthy controls, even though clinical remission had already been achieved. Phosphorylation levels declined in patients on both originator infliximab and biosimilar during continued treatment. No significant differences were detected between the two medications after 12 months.Patients with psoriasis on infliximab have higher activation levels of PBMCs than do healthy controls, possibly reflecting systemic inflammation. Switching from the originator infliximab to biosimilar CT-P13 did not affect phosphorylation levels or clinical parameters, suggesting that CT-P13 is a noninferior treatment alternative to the originator infliximab." @default.
• W2776033345 created "2018-01-05" @default.
• W2776033345 creator A5015561854 @default.
• W2776033345 creator A5027152672 @default.
• W2776033345 creator A5028770811 @default.
• W2776033345 creator A5037132601 @default.
• W2776033345 creator A5050919057 @default.
• W2776033345 creator A5053648839 @default.
• W2776033345 creator A5070764431 @default.
• W2776033345 creator A5072638016 @default.
• W2776033345 creator A5080785900 @default.
• W2776033345 creator A5085410221 @default.
• W2776033345 date "2018-05-30" @default.
• W2776033345 modified "2023-10-01" @default.
• W2776033345 title "Phosphorylation of intracellular signalling molecules in peripheral blood cells from patients with psoriasis on originator or biosimilar infliximab" @default.
• W2776033345 cites W1614648489 @default.
• W2776033345 cites W1954102524 @default.
• W2776033345 cites W1972788947 @default.
• W2776033345 cites W1975330719 @default.
• W2776033345 cites W1987784314 @default.
• W2776033345 cites W1993073854 @default.
• W2776033345 cites W1996677952 @default.
• W2776033345 cites W1997273242 @default.
• W2776033345 cites W2000961759 @default.
• W2776033345 cites W2001837649 @default.
• W2776033345 cites W2011009038 @default.
• W2776033345 cites W2013395523 @default.
• W2776033345 cites W2016542787 @default.
• W2776033345 cites W2016897508 @default.
• W2776033345 cites W2019947683 @default.
• W2776033345 cites W2027168511 @default.
• W2776033345 cites W2041375669 @default.
• W2776033345 cites W2044227662 @default.
• W2776033345 cites W2079749507 @default.
• W2776033345 cites W2080063528 @default.
• W2776033345 cites W2080090843 @default.
• W2776033345 cites W2081482161 @default.
• W2776033345 cites W2086146843 @default.
• W2776033345 cites W2091824579 @default.
• W2776033345 cites W2121050884 @default.
• W2776033345 cites W2137785076 @default.
• W2776033345 cites W2141016525 @default.
• W2776033345 cites W2145045035 @default.
• W2776033345 cites W2149848093 @default.
• W2776033345 cites W2155729698 @default.
• W2776033345 cites W2157432727 @default.
• W2776033345 cites W2162768160 @default.
• W2776033345 cites W2165738271 @default.
• W2776033345 cites W2167826970 @default.
• W2776033345 cites W2181027106 @default.
• W2776033345 cites W2220062183 @default.
• W2776033345 cites W2300819791 @default.
• W2776033345 cites W2328912382 @default.
• W2776033345 cites W2465353761 @default.
• W2776033345 cites W2488309603 @default.
• W2776033345 cites W2523439769 @default.
• W2776033345 cites W2549511634 @default.
• W2776033345 cites W2561759163 @default.
• W2776033345 cites W2592535678 @default.
• W2776033345 cites W2606513711 @default.
• W2776033345 cites W2613299853 @default.
• W2776033345 cites W2613380263 @default.
• W2776033345 cites W2617114977 @default.
• W2776033345 cites W2617120623 @default.
• W2776033345 cites W2617191705 @default.
• W2776033345 cites W2618862705 @default.
• W2776033345 cites W962657022 @default.
• W2776033345 doi "https://doi.org/10.1111/bjd.16269" @default.
• W2776033345 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29274242" @default.
• W2776033345 hasPublicationYear "2018" @default.
• W2776033345 type Work @default.
• W2776033345 sameAs 2776033345 @default.
• W2776033345 citedByCount "4" @default.
• W2776033345 countsByYear W27760333452018 @default.
• W2776033345 countsByYear W27760333452020 @default.
• W2776033345 countsByYear W27760333452021 @default.
• W2776033345 crossrefType "journal-article" @default.
• W2776033345 hasAuthorship W2776033345A5015561854 @default.
• W2776033345 hasAuthorship W2776033345A5027152672 @default.
• W2776033345 hasAuthorship W2776033345A5028770811 @default.
• W2776033345 hasAuthorship W2776033345A5037132601 @default.
• W2776033345 hasAuthorship W2776033345A5050919057 @default.
• W2776033345 hasAuthorship W2776033345A5053648839 @default.
• W2776033345 hasAuthorship W2776033345A5070764431 @default.
• W2776033345 hasAuthorship W2776033345A5072638016 @default.
• W2776033345 hasAuthorship W2776033345A5080785900 @default.
• W2776033345 hasAuthorship W2776033345A5085410221 @default.
• W2776033345 hasBestOaLocation W27760333451 @default.
• W2776033345 hasConcept C126322002 @default.
• W2776033345 hasConcept C137061746 @default.
• W2776033345 hasConcept C17991360 @default.
• W2776033345 hasConcept C202751555 @default.
• W2776033345 hasConcept C203014093 @default.
• W2776033345 hasConcept C2777138892 @default.
• W2776033345 hasConcept C2780564577 @default.
• W2776033345 hasConcept C55493867 @default.
• W2776033345 hasConcept C59491497 @default.
• W2776033345 hasConcept C71924100 @default.
• W2776033345 hasConcept C86803240 @default.
• W2776033345 hasConcept C8891405 @default.

• next